The Treat Trial-moving ST-elevation myocardial infarction care forward, with more to do

Clyde W. Yancy*, Robert A. Harrington

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)399-400
Number of pages2
JournalJAMA cardiology
Volume3
Issue number5
DOIs
StatePublished - May 2018

Funding

Dr Harrington reports receiving grants from Astra, Bristol-Myers Squibb, Janssen, Novartis, Portola, the Medicines Company, Sanofi, and CSL Limited; personal fees from Amgen, Bayer, Element Science, Gilead, MyoKardia, and the Medicines Company; and serving on the board of directors of the American Heart Association and Stanford Health Care. No disclosures were reported.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this